Jim Z. Li

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, M. Dror Michaelson, Bruce G. Redman et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

Matthew H. Kulke, Heinz‐Josef Lenz, Neal J. Meropol et al. · Journal of Clinical Oncology · 2008 · 618 citations · Full text

Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial

David Cella, Jim Z. Li, Joseph C. Cappelleri et al. · Journal of Clinical Oncology · 2008 · 129 citations

Patient Reported Differences in Dry Eye Disease between Men and Women: Impact, Management, and Patient Satisfaction

Debra A. Schaumberg, Miki Uchino, William G. Christen et al. · PLoS ONE · 2013 · 121 citations · Full text

Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China

Warren Stevens, Desi Peneva, Jim Z. Li et al. · BMC Health Services Research · 2016 · 106 citations · Full text